Diagnosis and Management of Benign Liver Tumors

Laurence Chiche; Jean-Philippe Adam

doi:10.1055/s-0033-1351779

Seminars in Liver Disease, Inhaltsverzeichnis

Semin Liver Dis 2013; 33(03): 236-247
DOI: 10.1055/s-0033-1351779

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Diagnosis and Management of Benign Liver Tumors

Laurence Chiche

¹CHU Bordeaux, Haut-Lévèque Hospital, Department of Digestive Surgery, Pessac, F-33600, France; University of Bordeaux Segalen, Bordeaux, F-33076, France

,

Jean-Philippe Adam

¹CHU Bordeaux, Haut-Lévèque Hospital, Department of Digestive Surgery, Pessac, F-33600, France; University of Bordeaux Segalen, Bordeaux, F-33076, France

› Institutsangaben

Abstract

The widespread use of imaging modalities and the continuous improvement in their sensitivity have lead to an increasing number of incidental findings of focal liver masses, either solitary or multiple. Most of these so-called incidentalomas are benign and are discovered in healthy, asymptomatic patients. The main issue is to ensure the proper diagnosis, so that clear management recommendations can be provided. Surgery is rarely indicated in these circumstances. Infrequently, benign liver tumors are diagnosed because of symptoms or complications, and require urgent management including surgery as a major role in the cure. Due to better understanding of the clinical and pathological features of benign liver tumors, the increased accuracy of imaging tools, and improvement in surgical techniques (including laparoscopy), the management of these lesions has evolved. Here the clinical and biological features of the most common solid and cystic benign liver tumors are reviewed, and the key points of management focusing on the role of surgery, preventive or diagnostic, are addressed.

Keywords

benign liver tumor - hemangioma - focal nodular hyperplasia - hepatocellular adenoma - adenomatosis

Volltext

Referenzen

References
1 Rungsinaporn K, Phaisakamas T. Frequency of abnormalities detected by upper abdominal ultrasound. J Med Assoc Thai 2008; 91 (7) 1072-1075
2 Karhunen PJ. Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 1986; 39 (2) 183-188
3 Ishak KG, Rabin L. Benign tumors of the liver. Med Clin North Am 1975; 59 (4) 995-1013
4 Saegusa T, Ito K, Oba N , et al. Enlargement of multiple cavernous hemangioma of the liver in association with pregnancy. Intern Med 1995; 34 (3) 207-211
5 Lui W, Zhang S, Hu T, Wei F, Gao Y, Cheng N. Sex hormone receptors of hemangiomas in children. Chin Med J (Engl) 1997; 110 (5) 349-351
6 Gemer O, Moscovici O, Ben-Horin CL, Linov L, Peled R, Segal S. Oral contraceptives and liver hemangioma: a case-control study. Acta Obstet Gynecol Scand 2004; 83 (12) 1199-1201
7 Bioulac-Sage P, Laumonier H, Laurent C, Blanc JF, Balabaud C. Benign and malignant vascular tumors of the liver in adults. Semin Liver Dis 2008; 28 (3) 302-314
8 Bioulac-Sage P, Balabaud C, Bedossa P , et al; Laennec and Elves groups. Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol 2007; 46 (3) 521-527
9 Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985; 5 (6) 1194-1200
10 Kehagias D, Moulopoulos L, Antoniou A , et al. Focal nodular hyperplasia: imaging findings. Eur Radiol 2001; 11 (2) 202-212
11 Nguyen BN, Fléjou JF, Terris B, Belghiti J, Degott C. Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 1999; 23 (12) 1441-1454
12 Vilgrain V, Uzan F, Brancatelli G, Federle MP, Zappa M, Menu Y. Prevalence of hepatic hemangioma in patients with focal nodular hyperplasia: MR imaging analysis. Radiology 2003; 229 (1) 75-79
13 World Health Organization (WHO). Medical Eligibility Criteria for Contraceptive Use. 4th ed. Geneva, Switzerland: WHO ; 2009
14 Bouyn CI, Leclere J, Raimondo G , et al. Hepatic focal nodular hyperplasia in children previously treated for a solid tumor. Incidence, risk factors, and outcome. Cancer 2003; 97 (12) 3107-3113
15 Masetti R, Biagi C, Kleinschmidt K , et al. Focal nodular hyperplasia of the liver after intensive treatment for pediatric cancer: is hematopoietic stem cell transplantation a risk factor?. Eur J Pediatr 2011; 170 (6) 807-812
16 Bioulac-Sage P, Rebouissou S, Sa Cunha A , et al. Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 2005; 128 (5) 1211-1218
17 Federle MP, Brancatelli G. Imaging of benign hepatic masses. Semin Liver Dis 2001; 21 (2) 237-249
18 Nakanuma Y. Nodular regenerative hyperplasia of the liver: retrospective survey in autopsy series. J Clin Gastroenterol 1990; 12 (4) 460-465
19 Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990; 11 (5) 787-797
20 Mortele KJ, Ros PR. Benign liver neoplasms. Clin Liver Dis 2002; 6 (1) 119-145
21 Stromeyer FW, Ishak KG. Nodular transformation (nodular “regenerative” hyperplasia) of the liver. A clinicopathologic study of 30 cases. Hum Pathol 1981; 12 (1) 60-71
22 Arvanitaki M, Adler M. Nodular regenerative hyperplasia of the liver. A review of 14 cases. Hepatogastroenterology 2001; 48 (41) 1425-1429
23 Rooks JB, Ory HW, Ishak KG , et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 1979; 242 (7) 644-648
24 Dokmak S, Paradis V, Vilgrain V , et al. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 2009; 137 (5) 1698-1705
25 Søe KL, Søe M, Gluud C. Liver pathology associated with the use of anabolic-androgenic steroids. Liver 1992; 12 (2) 73-79
26 Edmondson HA, Reynolds TB, Henderson B, Benton B. Regression of liver cell adenomas associated with oral contraceptives. Ann Intern Med 1977; 86 (2) 180-182
27 Bühler H, Pirovino M, Akobiantz A , et al. Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use. Gastroenterology 1982; 82 (4) 775-782
28 Parangi S, Levine D, Henry A, Isakovich N, Pories S. Surgical gastrointestinal disorders during pregnancy. Am J Surg 2007; 193 (2) 223-232
29 Terkivatan T, de Wilt JH, de Man RA, Ijzermans JN. Management of hepatocellular adenoma during pregnancy. Liver 2000; 20 (2) 186-187
30 Martin NM, Abu Dayyeh BK, Chung RT. Anabolic steroid abuse causing recurrent hepatic adenomas and hemorrhage. World J Gastroenterol 2008; 14 (28) 4573-4575
31 Ronald M, Woodfield J, McCall J, Koea J. Hepatic adenomas in male patients. HPB (Oxford) 2004; 6 (1) 25-27
32 Labrune P, Trioche P, Duvaltier I, Chevalier P, Odièvre M. Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 1997; 24 (3) 276-279
33 Assy N, Nasser G, Djibre A, Beniashvili Z, Elias S, Zidan J. Characteristics of common solid liver lesions and recommendations for diagnostic workup. World J Gastroenterol 2009; 15 (26) 3217-3227
34 Erdogan D, Busch OR, van Delden OM, Ten Kate FJ, Gouma DJ, van Gulik TM. Management of spontaneous haemorrhage and rupture of hepatocellular adenomas. A single centre experience. Liver Int 2006; 26 (4) 433-438
35 Noels JE, van Aalten SM, van der Windt DJ , et al. Management of hepatocellular adenoma during pregnancy. J Hepatol 2011; 54 (3) 553-558
36 Cobey FC, Salem RR. A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg 2004; 187 (2) 181-191
37 Bioulac-Sage P, Laumonier H, Couchy G , et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009; 50 (2) 481-489
38 Cho SW, Marsh JW, Steel J , et al. Surgical management of hepatocellular adenoma: take it or leave it?. Ann Surg Oncol 2008; 15 (10) 2795-2803
39 Stoot JH, Coelen RJ, De Jong MC, Dejong CH. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) 2010; 12 (8) 509-522
40 Deneve JL, Pawlik TM, Cunningham S , et al. Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol 2009; 16 (3) 640-648
41 Galanski M, Jördens S, Weidemann J. [Diagnosis and differential diagnosis of benign liver tumors and tumor-like lesions]. Chirurg 2008; 79 (8) 707-721
42 Zucman-Rossi J, Jeannot E, Nhieu JT , et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006; 43 (3) 515-524
43 Bioulac-Sage P, Rebouissou S, Thomas C , et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007; 46 (3) 740-748
44 Bioulac-Sage P, Balabaud C, Wanless I. Focal nodular hyperplasia and hepatocellular adenoma. In: Bosman F, Carneiro F, Hruban R, Theise ND, , eds. World Health Organization Classification of Tumours of the Digestive tract. 2nd ed. Lyon, France: IARC; 2010: 198-204
45 Farges O, Ferreira N, Dokmak S, Belghiti J, Bedossa P, Paradis V. Changing trends in malignant transformation of hepatocellular adenoma. Gut 2011; 60 (1) 85-89
46 Paradis V, Champault A, Ronot M , et al. Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology 2007; 46 (1) 140-146
47 Flejou JF, Barge J, Menu Y , et al. Liver adenomatosis. An entity distinct from liver adenoma?. Gastroenterology 1985; 89 (5) 1132-1138
48 Veteläinen R, Erdogan D, de Graaf W , et al. Liver adenomatosis: re-evaluation of aetiology and management. Liver Int 2008; 28 (4) 499-508
49 Chiche L, Dao T, Salamé E , et al. Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature. Ann Surg 2000; 231 (1) 74-81
50 Chang Z, Zhang JM, Ying JQ, Ge YP. Characteristics and treatment strategy of hepatic angiomyolipoma: a series of 94 patients collected from four institutions. J Gastrointestin Liver Dis 2011; 20 (1) 65-69
51 Deng YF, Lin Q, Zhang SH, Ling YM, He JK, Chen XF. Malignant angiomyolipoma in the liver: a case report with pathological and molecular analysis. Pathol Res Pract 2008; 204 (12) 911-918
52 Martin-Benitez G, Marti-Bonmati L, Barber C, Vila R. Hepatic lipomas and steatosis: an association beyond chance. Eur J Radiol 2012; 81 (4) e491-e494
53 Itai Y, Saida Y. Pitfalls in liver imaging. Eur Radiol 2002; 12 (5) 1162-1174
54 Cook JR, Pfeifer JD, Dehner LP. Mesenchymal hamartoma of the liver in the adult: association with distinct clinical features and histological changes. Hum Pathol 2002; 33 (9) 893-898
55 Chang CS, Lin KC, Hwang SL, Shen CY, Sun MS. Nonparasitic hepatic cysts detected in ultrasonographic examination: analysis of 95 cases. Taiwan Yi Xue Hui Za Zhi 1989; 88 (4) 394-399
56 Larssen TB, Rørvik J, Hoff SR, Horn A, Rosendahl K. The occurrence of asymptomatic and symptomatic simple hepatic cysts. A prospective, hospital-based study. Clin Radiol 2005; 60 (9) 1026-1029
57 Carrim ZI, Murchison JT. The prevalence of simple renal and hepatic cysts detected by spiral computed tomography. Clin Radiol 2003; 58 (8) 626-629
58 Sanchez H, Gagner M, Rossi RL , et al. Surgical management of nonparasitic cystic liver disease. Am J Surg 1991; 161 (1) 113-118 , discussion 118–119
59 Erdogan D, van Delden OM, Rauws EA , et al. Results of percutaneous sclerotherapy and surgical treatment in patients with symptomatic simple liver cysts and polycystic liver disease. World J Gastroenterol 2007; 13 (22) 3095-3100
60 Takahashi G, Yoshida H, Mamada Y, Taniai N, Bando K, Tajiri T. Journal of Nippon Medical School. Intracystic hemorrhage of a large simple hepatic cyst. J Nippon Med Sch 2008; 75 (5) 302-305
61 Ishikawa H, Uchida S, Yokokura Y , et al. Nonparasitic solitary huge liver cysts causing intracystic hemorrhage or obstructive jaundice. J Hepatobiliary Pancreat Surg 2002; 9 (6) 764-768
62 England RA, Wells IP, Gutteridge CM. Benign external compression of the inferior vena cava associated with thrombus formation. Br J Radiol 2005; 78 (930) 553-557
63 Poggi G, Gatti C, Delmonte A, Teragni C, Bernardo G. Spontaneous rupture of non-parasitic hepatic cyst. Int J Clin Pract 2006; 60 (1) 99-103
64 Klingler PJ, Gadenstätter M, Schmid T, Bodner E, Schwelberger HG. Treatment of hepatic cysts in the era of laparoscopic surgery. Br J Surg 1997; 84 (4) 438-444
65 Karhunen PJ, Tenhu M. Adult polycystic liver and kidney diseases are separate entities. Clin Genet 1986; 30 (1) 29-37
66 Torres VE, Harris PC. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 2009; 76 (2) 149-168
67 Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med 1993; 329 (5) 332-342
68 Gabow PA, Johnson AM, Kaehny WD, Manco-Johnson ML, Duley IT, Everson GT. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 1990; 11 (6) 1033-1037
69 Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 2007; 369 (9569) 1287-1301
70 Sherstha R, McKinley C, Russ P , et al. Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease. Hepatology 1997; 26 (5) 1282-1286
71 Grantham JJ. Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med 2008; 359 (14) 1477-1485
72 Bistritz L, Tamboli C, Bigam D, Bain VG. Polycystic liver disease: experience at a teaching hospital. Am J Gastroenterol 2005; 100 (10) 2212-2217
73 Gigot JF, Jadoul P, Que F , et al. Adult polycystic liver disease: is fenestration the most adequate operation for long-term management?. Ann Surg 1997; 225 (3) 286-294
74 Schnelldorfer T, Torres VE, Zakaria S, Rosen CB, Nagorney DM. Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation. Ann Surg 2009; 250 (1) 112-118
75 Dixon E, Sutherland FR, Mitchell P, McKinnon G, Nayak V. Cystadenomas of the liver: a spectrum of disease. Can J Surg 2001; 44 (5) 371-376
76 Palacios E, Shannon M, Solomon C, Guzman M. Biliary cystadenoma: ultrasound, CT, and MRI. Gastrointest Radiol 1990; 15 (4) 313-316
77 Marcial MA, Hauser SC, Cibas ES, Braver J. Intrahepatic biliary cystadenoma. Clinical, radiological, and pathological findings. Dig Dis Sci 1986; 31 (8) 884-888
78 Buetow PC, Buck JL, Pantongrag-Brown L , et al. Biliary cystadenoma and cystadenocarcinoma: clinical-imaging-pathologic correlations with emphasis on the importance of ovarian stroma. Radiology 1995; 196 (3) 805-810
79 Devaney K, Goodman ZD, Ishak KG. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol 1994; 18 (11) 1078-1091
80 Ishak KG, Willis GW, Cummins SD, Bullock AA. Biliary cystadenoma and cystadenocarcinoma: report of 14 cases and review of the literature. Cancer 1977; 39 (1) 322-338
81 Florman SS, Slakey DP. Giant biliary cystadenoma: case report and literature review. Am Surg 2001; 67 (8) 727-732
82 Albiin N. MRI of focal liver lesions. Curr Med Imaging Rev 2012; 8 (2) 107-116
83 Heiken JP. Distinguishing benign from malignant liver tumours. Cancer Imaging 2007; 7 (Spec No A): S1-14
84 Stoot JH, Coelen RJ, De Jong MC, Dejong CH. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) 2010; 12 (8) 509-522
85 van Aalten SM, de Man RA, IJzermans JN, Terkivatan T. Systematic review of haemorrhage and rupture of hepatocellular adenomas. Br J Surg 2012; 99 (7) 911-916
86 Lewin M, Handra-Luca A, Arrivé L , et al. Liver adenomatosis: classification of MR imaging features and comparison with pathologic findings. Radiology 2006; 241 (2) 433-440
87 Noels JE, van Aalten SM, van der Windt DJ , et al. Management of hepatocellular adenoma during pregnancy. J Hepatol 2011; 54 (3) 553-558
88 Kobayashi S, Sakaguchi H, Takatsuka M , et al. Two cases of hepatocellular adenomatosis treated with transcatheter arterial embolization. Hepatol Int 2009; 3 (2) 416-420
89 Ishizawa T, Gumbs AA, Kokudo N, Gayet B. Laparoscopic segmentectomy of the liver: from segment I to VIII. Ann Surg 2012; 256 (6) 959-964
90 Toro A, Gagner M, Di Carlo I. Has laparoscopy increased surgical indications for benign tumors of the liver?. Langenbecks Arch Surg 2013; 398 (2) 195-210
91 Lin NC, Nitta H, Wakabayashi G. Laparoscopic major hepatectomy: a systematic literature review and comparison of 3 techniques. Ann Surg 2013; 257 (2) 205-213
92 Lerner SM, Hiatt JR, Salamandra J , et al. Giant cavernous liver hemangiomas: effect of operative approach on outcome. Arch Surg 2004; 139 (8) 818-821 , discussion 821–823
93 Vagefi PA, Eilers H, Hiniker A, Freise CE. Liver transplantation for giant hepatic angiomyolipoma. Liver Transpl 2011; 17 (8) 985-986
94 Vagefi PA, Klein I, Gelb B , et al. Emergent orthotopic liver transplantation for hemorrhage from a giant cavernous hepatic hemangioma: case report and review. J Gastrointest Surg 2011; 15 (1) 209-214
95 Marino IR, Scantlebury VP, Bronsther O, Iwatsuki S, Starzl TE. Total hepatectomy and liver transplant for hepatocellular adenomatosis and focal nodular hyperplasia. Transpl Int 1992; 5 (Suppl. 01) S201-S205
96 Lerut J, Ciccarelli O, Rutgers M , et al. Liver transplantation with preservation of the inferior vena cava in case of symptomatic adult polycystic disease. Transpl Int 2005; 18 (5) 513-518
97 Shaked O, Siegelman ES, Olthoff K, Reddy KR. Biologic and clinical features of benign solid and cystic lesions of the liver. Clin Gastroenterol Hepatol 2011; 9 (7) 547-562 , e1–e4